Airway cellular response to two different immunosuppressive regimens in lung transplant recipients Source: Eur Respir J 2004; 24: Suppl. 48, 466s Year: 2004
Increased LIR-1 expression precedes serum cytomegalovirus detection and diagnosis of CMV disease in lung transplant recipients Source: Eur Respir J 2002; 20: Suppl. 38, 347s Year: 2002
Monitoring T-cell immunity towards M. tuberculosis : impaired specific immunocompetence in patients receiving high levels of immunosuppressive drugs Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008
Th1\Th2 lymphocyte response during the course of lung infection in CF children Source: Eur Respir J 2006; 28: Suppl. 50, 484s Year: 2006
Basiliximab induction reduces the incidence of acute rejection in lung transplant patients Source: International Congress 2018 – Moving lung transplantation forward Year: 2018
SARS-CoV-2 T-cell response in COVID-19 convalescent patients with and without lung sequelae Source: ERJ Open Res, 8 (1) 00706-2021; 10.1183/23120541.00706-2021 Year: 2022
Cytomegalovirus-specific cell-mediated immunity after prophylaxis predicts late-onset infection in lung transplantation Source: Virtual Congress 2020 – Clinical management of lung transplant recipients Year: 2020
The role of increasing TIM3 on T cells in patients with nontuberculous mycobacterial lung disease: from immune cell dysfunction to clinical severity Source: Virtual Congress 2021 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and nontuberculous mycobacterial disease Year: 2021
Preemptive therapy for systemic and pulmonary human cytomegalovirus infection in lung transplant recipients Source: Annual Congress 2009 - Lung transplantation: pre- and postoperative problems Year: 2009
CMV management in lung transplant recipients Source: School Course 2012 - Lung Transplantation Year: 2012
The humoral immune response to influenza vaccination in lung transplant patients Source: Eur Respir J 2001; 18: 971-976 Year: 2001
The status of populations of cell-mediated lung immunity effectors after chemotherapy of experimental MDR tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 656s Year: 2005
Increasing immunosuppression despite high load of respiratory viruses: Fludarabine as rescue treatment in alloreactive lung disease Source: Annual Congress 2011 - Paediatric respiratory infection: signs, symptoms and sequelae Year: 2011
Characteristics, treatment and outcomes of nontuberculous mycobacterial pulmonary disease after allogeneic haematopoietic stem cell transplant Source: Eur Respir J, 51 (5) 1702330; 10.1183/13993003.02330-2017 Year: 2018
Use of immune cell function assay in immune surveillance of lung transplant recipients: Correlations with clinical outcome and other immune assays Source: Annual Congress 2012 - Optimising outcomes after lung transplantation Year: 2012
Pronounced neutrophil-rich inflammation in induced sputum of lung transplant recipients with chronic rejection Source: Eur Respir J 2001; 18: Suppl. 33, 297s Year: 2001
Diagnosis of latent tuberculosis infection in patients with chronic liver disease undergoing liver transplantation: performance of the new IFN-γ-based assays Source: Eur Respir J 2007; 30: Suppl. 51, 752s Year: 2007
Specificities of the paediatric lung transplant recipient Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients Year: 2005
T lymphocyte subgroups and tuberculin skin test reactivity in patients with chronic renal failure Source: Eur Respir J 2004; 24: Suppl. 48, 426s Year: 2004
Tuberculine skin testing response in patients with chronic renal failure Source: Eur Respir J 2004; 24: Suppl. 48, 647s Year: 2004